Cargando…
Multilesional pyoderma gangrenosum is associated with longer healing times and higher rates of underlying comorbidities: A single-center prospective registry study
Autores principales: | Zhao, Hannah, Mostaghimi, Arash, Sisley, Jonathan M., Ortega-Loayza, Alex G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319331/ https://www.ncbi.nlm.nih.gov/pubmed/37409315 http://dx.doi.org/10.1016/j.jdin.2023.05.009 |
Ejemplares similares
Ejemplares similares
-
Pyoderma Gangrenosum: Treatment Options
por: Dissemond, Joachim, et al.
Publicado: (2023) -
Two cases of maggot debridement therapy in pyoderma gangrenosum
por: Din, Ryan S., et al.
Publicado: (2018) -
Modified dose of guselkumab for treatment of pyoderma gangrenosum
por: Reese, Ashley M., et al.
Publicado: (2022) -
Recalcitrant Pyoderma Gangrenosum: Clinical Burden and Unmet Needs
por: Becker, Sarah L, et al.
Publicado: (2023) -
Pyoderma gangrenosum is no longer a diagnosis of exclusion
por: Dissemond, Joachim
Publicado: (2021)